10X GENOMICS INC's ticker is TXG and the CUSIP is 88025U109. A total of 364 filers reported holding 10X GENOMICS INC in Q4 2021. The put-call ratio across all filers is 0.41 and the average weighting 1.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $127,095,581 | -26.0% | 3,081,105 | +0.1% | 1.95% | -20.1% |
| Q2 2023 | $171,852,123 | +0.2% | 3,077,581 | +0.1% | 2.44% | -5.0% |
| Q1 2023 | $171,587,110 | +223.9% | 3,075,589 | +111.6% | 2.56% | +192.8% |
| Q4 2022 | $52,970,277 | +15.2% | 1,453,630 | -10.0% | 0.88% | +35.8% |
| Q3 2022 | $45,998,000 | -58.2% | 1,615,093 | -33.6% | 0.64% | -56.2% |
| Q2 2022 | $110,001,000 | -13.1% | 2,430,955 | +46.1% | 1.47% | +17.0% |
| Q1 2022 | $126,540,000 | -32.2% | 1,663,469 | +32.7% | 1.26% | -18.5% |
| Q4 2021 | $186,666,000 | +1.7% | 1,253,129 | -0.6% | 1.54% | +2.7% |
| Q3 2021 | $183,601,000 | -23.7% | 1,261,171 | +2.6% | 1.50% | -17.5% |
| Q2 2021 | $240,601,000 | +96.0% | 1,228,685 | +81.1% | 1.82% | +99.6% |
| Q1 2021 | $122,780,000 | +89.2% | 678,341 | +48.0% | 0.91% | +104.0% |
| Q4 2020 | $64,887,000 | – | 458,241 | – | 0.45% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management I, LLC | 750,000 | $111,720,000 | 99.68% |
| Foresite Capital Management II, LLC | 1,753,528 | $261,206,000 | 99.34% |
| Venrock Management VI, LLC | 962,309 | $143,346,000 | 96.17% |
| 12 West Capital Management LP | 2,004,000 | $298,516,000 | 13.24% |
| FINANCIAL CONSULATE, INC | 154,942 | $23,080,000 | 8.00% |
| Meritech Capital Associates V L.L.C. | 1,610,824 | $239,948,000 | 7.68% |
| Andar Capital Management HK Ltd | 55,000 | $8,193,000 | 7.52% |
| JS Capital Management LLC | 540,589 | $80,526,000 | 3.66% |
| HARVARD MANAGEMENT CO INC | 186,143 | $27,728,000 | 2.60% |
| Connective Portfolio Management, LLC | 7,000 | $1,056,000 | 1.86% |